EP3730136
USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.6.2013:
27.12.2023:
20163104.1
:
20.6.2033
:
USE OF FERRIC CITRATE IN THE TREATMENT OF CHRONIC KIDNEY DISEASE PATIENTS
21.6.2013
27.12.2023
:
Keryx Biopharmaceuticals, Inc.:
245 First Street, Suite 1400, Cambridge, MA 02142, US
:
PORADOSU, Enrique:
Brookline, MA 02445, US
:
BENTSUR, Ron:
Tenafly, NJ New Jersey 07670, US
:
OLIVIERO III, James F.:
New York, NY New York 10013, US
:
201261662565 P:
21.6.2012:
US
:
201361757229 P:
28.1.2013:
US
:
201361801050 P:
15.3.2013:
US
:
201361800618 P:
15.3.2013:
US
:
A61K 31/295, A61P 3/00, A61P 7/06, A61P 13/12, A61K 9/28